Addressing Language Barriers in Pulmonary Function Testing: Effects on Lab Quality and Patient Outcomes
-
By
-
David A. Kaminsky
-
July 14, 2026
By
David A. Kaminsky
July 14, 2026
by David A. Kaminsky
July 14, 2026
Phase 3 SUNRISE trial evaluates whether patients with severe asthma can taper maintenance oral corticosteroids while maintaining asthma control.
June 25, 2026
A structured framework of guidelines, trials, therapies, and tools used in clinical practice.
September 29, 2026
A cross-sectional metagenomic study found greater oral microbiome richness among adults with chronic rhinosinusitis, particularly nonallergic chronic rhinosinusitis, while associations with asthma, airway inflammation, and most lung-function measures were inconsistent.
July 8, 2026